Weekly Valvular Heart Disease Publication Update

1. Rationale and Design of the CREATE Trial: A Multicenter, Randomized Comparison of Continuation or Cessation of Single Antithrombotic Therapy at 1 Year After Transcatheter Aortic Valve Replacement.
   J Am Heart Assoc. 2025 Mar 21:e039350. doi: 10.1161/JAHA.124.039350. Online ahead of print. PMID: 40118800 Free article.
   
   
2. Cerebral Embolic Protection Devices in Transcatheter Aortic Valve Implantation: Meta-Analysis With Trial Sequential Analysis.
   J Am Heart Assoc. 2025 Mar 21:e038869. doi: 10.1161/JAHA.124.038869. Online ahead of print. PMID: 40118799 Free article.
   
   
3. Lipoprotein (a) Distribution in Aortic Stenosis Patients: Are Lp(a) Reducing Agents the Ultimate Solution?
   JACC Adv. 2025 Mar 20;4(4):101662. doi: 10.1016/j.jacadv.2025.101662. Online ahead of print. PMID: 40117697 Free article.
   
   
4. Temporal Trends in 1-Year Cause-Specific Mortality After TAVR: Insights From the STS/ACC TVT Registry.
   JACC Cardiovasc Interv. 2025 Feb 1:S1936-8798(24)01950-2. doi: 10.1016/j.jcin.2024.12.016. Online ahead of print. PMID: 40117414
   
   
5. Transesophageal Echocardiography Guidance Is Useful for Valve-in-Valve Transcatheter Aortic Valve Replacement.
   JACC Cardiovasc Interv. 2025 Feb 24:S1936-8798(25)00611-9. doi: 10.1016/j.jcin.2025.01.443. Online ahead of print. PMID: 40117413
   
   
6. Is it Time to Focus on Patients Rather Than Procedures to Improve Outcomes After TAVR?
   JACC Cardiovasc Interv. 2025 Feb 19:S1936-8798(25)00423-6. doi: 10.1016/j.jcin.2025.01.419. Online ahead of print. PMID: 40117410
   
   
7. Embolic Protection Device Use With Transcatheter Aortic Valve Replacement After PROTECTED TAVR Trial.
   JACC Cardiovasc Interv. 2025 Feb 24:S1936-8798(25)00613-2. doi: 10.1016/j.jcin.2025.01.445. Online ahead of print. PMID: 40117409
   
   
8. Understanding 30-Day Out-of-Hospital Mortality After Mitral TEER: Predictors, Challenges, and Opportunities for Improvement.
   JACC Cardiovasc Interv. 2025 Mar 13:S1936-8798(25)00786-1. doi: 10.1016/j.jcin.2025.02.005. Online ahead of print. PMID: 40117408
   
   
9. Partial Dyscoaptation of SAPIEN 3 Ultra RESILIA Treated by Post-Ballooning During Transcatheter Aortic Valve Replacement.
   JACC Cardiovasc Interv. 2025 Feb 24:S1936-8798(25)00616-8. doi: 10.1016/j.jcin.2025.01.448. Online ahead of print. PMID: 40117407
   
   
10. Out-of-Hospital 30-Day Mortality After Mitral TEER: Insights From the STS/ACC TVT Registry.
    JACC Cardiovasc Interv. 2025 Feb 25:S1936-8798(25)00496-0. doi: 10.1016/j.jcin.2025.01.425. Online ahead of print.

View More

1. Imaging and Surveillance of Chronic Aortic Dissection: Current Practice and Future Directions.
   Heart Lung Circ. 2025 Mar 13:S1443-9506(25)00001-0. doi: 10.1016/j.hlc.2024.11.035. Online ahead of print. PMID: 40087054 Review.
   
   
2. Navigating the prognostic risk stratification of moderate and severe asymptomatic aortic stenosis.
   Int J Cardiol. 2025 Mar 12:133141. doi: 10.1016/j.ijcard.2025.133141. Online ahead of print. PMID: 40086673
   
   
3. Toward non-invasive assessment of myocardial work using myocardial stiffness and strain: a human pilot study.
   Eur Heart J Cardiovasc Imaging. 2025 Mar 14:jeaf089. doi: 10.1093/ehjci/jeaf089. Online ahead of print. PMID: 40085822
   
   
4. Aortic root repair using reimplantation or remodelling with and without an annuloplasty: A need for randomized studies.
   Eur J Cardiothorac Surg. 2025 Mar 14:ezaf078. doi: 10.1093/ejcts/ezaf078. Online ahead of print. PMID: 40085018
   
   
5. Follow-up of incidentally detected mild to moderate ascending aortic dilation and risk factors for rapid progression in a Swedish middle-aged population.
   Heart. 2025 Mar 13:heartjnl-2024-325409. doi: 10.1136/heartjnl-2024-325409. Online ahead of print. PMID: 40081936
   
   
6. Different Surgical Approaches for Acute Type I Aortic Dissections.
   Ann Thorac Surg. 2025 Mar 11:S0003-4975(25)00183-3. doi: 10.1016/j.athoracsur.2025.02.015. Online ahead of print. PMID: 40081558
   
   
7. Cardiac power is associated with extracellular volume and exercise capacity in asymptomatic moderate-to-severe aortic stenosis.
   Eur Heart J Cardiovasc Imaging. 2025 Mar 13:jeaf087. doi: 10.1093/ehjci/jeaf087. Online ahead of print. PMID: 40080712
   
   
8. Implant mechanical aortic valves (m-AVR) and start anticoagulation and save young patients (<70 years) or "dogs howl and the caravan will move on".
   Eur J Cardiothorac Surg. 2025 Mar 13:ezaf086. doi: 10.1093/ejcts/ezaf086. Online ahead of print. PMID: 40080708
   
   
9. Long-Term Outcomes After Transcatheter Aortic Valve Replacement Complicated by New-Onset Persistent Left Bundle Branch Block.
   Catheter Cardiovasc Interv. 2025 Mar 13. doi: 10.1002/ccd.31491. Online ahead of print. PMID: 40079520
   
   
10. TAVI or TAVR: it is time to use a single standardized acronym for percutaneous aortic valve implantation.
    Eur Heart J. 2025 Mar 13:ehaf048. doi: 10.1093/eurheartj/ehaf048. Online ahead of print.

View More

1. Determinants of ascending aortic morphology: Cross-sectional deep learning-based analysis on 25,073 non-contrast-enhanced NAKO MRI studies
   Eur Heart J Cardiovasc Imaging. 2025 Mar 7:jeaf081. doi: 10.1093/ehjci/jeaf081. Online ahead of print.
   
   
2. Epicardial adipose tissue, myocardial remodelling and adverse outcomes in asymptomatic aortic stenosis: a post hoc analysis of a randomised controlled trial
   Heart. 2025 Mar 6:heartjnl-2024-324925. doi: 10.1136/heartjnl-2024-324925. Online ahead of print.
   
   
3. Current practices for cohort reporting and statistical adjustment in studies from the STS Adult Cardiac Surgery Database
   Ann Thorac Surg. 2025 Mar 4:S0003-4975(25)00178-X. doi: 10.1016/j.athoracsur.2025.02.011. Online ahead of print.
   
   
4. Transcatheter Mitral Valve Replacement in Severe Mitral Annular Calcification: BATMAN and ROBIN, the Dynamic Duo
   JACC Cardiovasc Interv. 2025 Feb 21:S1936-8798(25)00504-7. doi: 10.1016/j.jcin.2025.01.431. Online ahead of print.
   
   
5. Residual Mitral Regurgitation Predicts Survival Independent of Mitral Valve Pressure Gradient Following Transcatheter Edge-to-Edge Repair
   JACC Cardiovasc Interv. 2025 Feb 10:S1936-8798(25)00424-8. doi: 10.1016/j.jcin.2025.01.420. Online ahead of print.
   
   
6. Timing and Mechanism of Intraprocedural Conduction Disturbances in Transcatheter Aortic Valve Replacement With Evolut Platform
   JACC Cardiovasc Interv. 2025 Feb 18:S1936-8798(25)00011-1. doi: 10.1016/j.jcin.2025.01.008. Online ahead of print.
   
   
7. Effectiveness of Transcatheter Aortic Valve Replacement on Acquired von Willebrand Syndrome: A Prospective Cohort Study
   JACC Cardiovasc Interv. 2025 Feb 15:S1936-8798(25)00009-3. doi: 10.1016/j.jcin.2025.01.006. Online ahead of print.
   
   
8. Transcatheter Repair in Posterior, Anterior, and Bileaflet Mitral Valve Disease: 1-Year Results From EXPANDed
   JACC Cardiovasc Interv. 2025 Jan 27:S1936-8798(24)01958-7. doi: 10.1016/j.jcin.2024.12.023. Online ahead of print.
   
   
9. Anterior, Posterior, or Bileaflet Mitral Valve Pathology: No Reason to Worry With M-TEER!
   JACC Cardiovasc Interv. 2025 Feb 24:S1936-8798(25)00501-1. doi: 10.1016/j.jcin.2025.01.430. Online ahead of print.
   
   
10. Hypertrophic Cardiomyopathy: State of the Art
    Mayo Clin Proc. 2025 Mar;100(3):557-566. doi: 10.1016/j.mayocp.2024.07.013.

View More

1. Assessment of the GLIDE Score for Prediction of Mild Tricuspid Regurgitation following Tricuspid Transcatheter Edge-to-Edge Repair.
   JACC Adv. 2025 Feb;4(2):101523. doi: 10.1016/j.jacadv.2024.101523. PMID: 40021274 Free article.
   
   
2. Clinical Outcomes of Direct Oral Anticoagulant Versus Warfarin After Transcatheter Aortic Valve Replacement: From the STS/ACC TVT Registry.
   Am Heart J. 2025 Feb 26:S0002-8703(25)00057-2. doi: 10.1016/j.ahj.2025.02.019. Online ahead of print. PMID: 40020964
   
   
3. Management of Cardiac Implantable Electronic Devices in Patients With Severe Symptomatic Tricuspid Regurgitation-Proposed Algorithm and Selected Case Examples.
   Catheter Cardiovasc Interv. 2025 Feb 28. doi: 10.1002/ccd.31444. Online ahead of print. PMID: 40018907
   
   
4. Combined Mitraclip Redo and Triclip Transcatheter Edge-to-Edge Repair Using Triclip Guide Catheter: A Case Report Demonstrating Its Feasibility.
   Catheter Cardiovasc Interv. 2025 Feb 28. doi: 10.1002/ccd.31470. Online ahead of print. PMID: 40018837
   
   
5. Surgical versus Transcatheter Aortic Valve Replacement in Patients 65 Years of Age and Older.
   Ann Thorac Surg. 2025 Feb 25:S0003-4975(25)00165-1. doi: 10.1016/j.athoracsur.2025.02.003. Online ahead of print. PMID: 40015547
   
   
6. Apical Access Management in Transapical Transcatheter Mitral Valve Replacement.
   Ann Thorac Surg. 2025 Feb 25:S0003-4975(25)00164-X. doi: 10.1016/j.athoracsur.2025.01.035. Online ahead of print. PMID: 40015546 Free article.
   
   
7. Epidemiological Profile and Mortality of Infective Endocarditis over the past decade: A Systematic Review and Meta-analysis of 133 Studies.
   Am J Cardiol. 2025 Feb 25:S0002-9149(25)00110-9. doi: 10.1016/j.amjcard.2025.02.023. Online ahead of print. PMID: 40015544 Review.
   
   
8. Incidentally Detected Ascending Thoracic Aortic Aneurysm and Bicuspid Aortic Valve.
   JAMA. 2025 Feb 27. doi: 10.1001/jama.2024.27691. Online ahead of print. PMID: 40014351
   
   
9. What Is Calcific Aortic Stenosis?
   JAMA. 2025 Feb 27. doi: 10.1001/jama.2025.0667. Online ahead of print. PMID: 40014328
   
   
10. Incidentally Detected Ascending Thoracic Aortic Aneurysm and Bicuspid Aortic Valve-Reply.
    JAMA. 2025 Feb 27. doi: 10.1001/jama.2024.27694. Online ahead of print.

View More

1. Prognostic implications of the left atrial stiffness index in patients with cardiac amyloidosis.
   Int J Cardiol. 2025 Feb 20:133087. doi: 10.1016/j.ijcard.2025.133087. Online ahead of print.
   
   
2. Lower Rates of Abdominal Aortic Aneurysm Repair and Higher Long-term Aortic Mortality in Women Compared With Men: Results of a Population-Based Study Spanning 4 Decades.
   Mayo Clin Proc. 2025 Feb 13:S0025-6196(24)00663-3. doi: 10.1016/j.mayocp.2024.11.027. Online ahead of print.
   
   
3. SGLT2 Inhibition in Aortic Stenosis: A Therapy for the Ventricle, the Valve, or Both?
   JACC Cardiovasc Interv. 2025 Jan 27:S1936-8798(24)01963-0. doi: 10.1016/j.jcin.2024.12.025. Online ahead of print.
   
   
4. A Novel Self-Centering Aortic Valve Crossing Catheter for Transcatheter Aortic Valve Replacement.
   JACC Cardiovasc Interv. 2025 Jan 22:S1936-8798(24)01828-4. doi: 10.1016/j.jcin.2024.11.039. Online ahead of print.
   
   
5. Effect of Sodium-Glucose Cotransporter-2 Inhibitors on the Progression of Aortic Stenosis.
   JACC Cardiovasc Interv. 2025 Feb 6:S1936-8798(24)01821-1. doi: 10.1016/j.jcin.2024.11.036. Online ahead of print.
   
   
6. One-Year Recurrent Tricuspid Regurgitation after Successful Transcatheter Edge to Edge Repair: the TRI-SPA Registry.
   Am J Cardiol. 2025 Feb 19:S0002-9149(25)00084-0. doi: 10.1016/j.amjcard.2025.02.010. Online ahead of print.
   
   
7. Ventricular-Arterial Coupling is associated with Clinical Outcomes in Patients with Systemic Right Ventricle.
   Am Heart J. 2025 Feb 19:S0002-8703(25)00043-2. doi: 10.1016/j.ahj.2025.02.013. Online ahead of print.
   
   
8. Outcomes of 230 Patients Undergoing Surgical Repair of Anomalous Aortic Origin of a Coronary Artery.
   Ann Thorac Surg. 2025 Feb 19:S0003-4975(25)00119-5. doi: 10.1016/j.athoracsur.2025.01.029. Online ahead of print.
   
   
9. Left Atrial and Ventricular Remodeling in Chronic Mitral Regurgitation.
   J Thorac Cardiovasc Surg. 2025 Feb 19:S0022-5223(25)00124-2. doi: 10.1016/j.jtcvs.2025.02.011. Online ahead of print.
   
   
10. Understanding the Effects of Mitral Transcatheter Edge-to-Edge Repair on Left Ventricular Function Using Pressure-Volume Loops.
    JACC Adv. 2025 Feb 19;4(3):101627. doi: 10.1016/j.jacadv.2025.101627. Online ahead of print.

View More

1. Survival After Endocarditis Surgery Needing Venoarterial Extracorporeal Membrane Oxygenation Support: Results from the Netherlands Heart Registration.
   Am J Cardiol. 2025 Feb 13:S0002-9149(25)00080-3. doi: 10.1016/j.amjcard.2025.02.005. Online ahead of print. PMID: 39954915 Free article.
   
   
2. Aortic valve stenosis - severe or not, that is the question!
   J Cardiol. 2025 Feb 13:S0002-9149(25)00082-7. doi: 10.1016/j.amjcard.2025.02.009. Online ahead of print. PMID: 39954914
   
   
3. Coronary physiology assessment in severe aortic stenosis: Feasible yet challenging.
   Int J Cardiol. 2025 Feb 13:133063. doi: 10.1016/j.ijcard.2025.133063. Online ahead of print. PMID: 39954787
   
   
4. The Impact of Frailty on VARC-3 Integrated Outcomes in Patients Undergoing Transcatheter Aortic Valve Replacement.
   JACC Adv. 2025 Feb 14;4(3):101594. doi: 10.1016/j.jacadv.2025.101594. Online ahead of print. PMID: 39954343
   
   
5. Enhanced Survival With Surgical Ablation of Atrial Fibrillation During Mitral Valve Surgery.
   J. Ann Thorac Surg. 2025 Feb 12:S0003-4975(25)00115-8. doi: 10.1016/j.athoracsur.2025.01.026. Online ahead of print. PMID: 39952581
   
   
6. Transcatheter or Surgical Aortic Valve Replacement in patients with Severe Aortic Stenosis Aged 70 Years or Younger - a NOTION-2 sub-study.
   Am Heart J. 2025 Feb 12:S0002-8703(25)00034-1. doi: 10.1016/j.ahj.2025.02.003. Online ahead of print. PMID: 39952377
   
   
7. Direct perfusion for mesenteric ischemia in acute type A aortic dissection: a glimpse into the mist of uncertainties.
   Eur J Cardiothorac Surg. 2025 Feb 13:ezaf044. doi: 10.1093/ejcts/ezaf044. Online ahead of print. PMID: 39951261
   
   
8. Current status of aortic valve repair surgery.
   Eur Heart J. 2025 Feb 14:ehaf038. doi: 10.1093/eurheartj/ehaf038. Online ahead of print. PMID: 39950993
   
   
9. Weekly Journal Scan: transcatheter vs. surgical treatment of combined severe aortic valve stenosis and obstructive coronary artery disease.
   Eur Heart J. 2025 Feb 14:ehaf023. doi: 10.1093/eurheartj/ehaf023. Online ahead of print. PMID: 39950980
   
   
10. The potential role of apolipoprotein A-1 amyloid in aortic dissection.
    Eur Heart J. 2025 Feb 14:ehaf096. doi: 10.1093/eurheartj/ehaf096. Online ahead of print.

View More

1. Melanocortin 1 Receptor Regulates Pathological and Physiological Cardiac Remodeling
   J Am Heart Assoc. 2025 Feb 8:e037961. doi: 10.1161/JAHA.124.037961. Online ahead of print. PMID: 39921516 Free article.
   
   
2. One-Year Functional Outcome of Patients After Surgery for Acute Stanford Type A Aortic Dissection
   J Am Heart Assoc. 2025 Feb 8:e036495. doi: 10.1161/JAHA.124.036495. Online ahead of print. PMID: 39921513 Free article.
   
   
3. Association Between Inflammatory Arthritis, Genetic Risk, and the Long-Term Risk of Degenerative Aortic Stenosis: A Prospective Cohort Study
   J Am Heart Assoc. 2025 Feb 8:e038815. doi: 10.1161/JAHA.124.038815. Online ahead of print. PMID: 39921509 Free article.
   
   
4. Fabry Cardiomyopathy: Myocardial Fibrosis, Inflammation, and Down-Regulation of Mannose-6-Phosphate Receptors Cause Low Accessibility to Enzyme Replacement Therapy
   J Am Heart Assoc. 2025 Feb 8:e036815. doi: 10.1161/JAHA.124.036815. Online ahead of print. PMID: 39921501 Free article.
   
   
5. AQG Analysis of an Aortic Surgeon's Lifetime Experience: Step Into The New Age
   J Thorac Cardiovasc Surg. 2025 Feb 5:S0022-5223(25)00097-2. doi: 10.1016/j.jtcvs.2025.01.026. Online ahead of print. PMID: 39921121
   
   
6. Bailout Coiling During Transcatheter Edge-to-Edge Mitral Valve Repair
   JACC Cardiovasc Interv. 2025 Jan 13:S1936-8798(24)01857-0. doi: 10.1016/j.jcin.2024.12.008. Online ahead of print. PMID: 39918503
   
   
7. Transcatheter Edge-to-Edge Repair for Severe Tricuspid Regurgitation in Dextro-Transposition of Great Arteries Post Mustard Procedure
   JACC Cardiovasc Interv. 2025 Jan 16:S1936-8798(24)01859-4. doi: 10.1016/j.jcin.2024.12.009. Online ahead of print. PMID: 39918502
   
   
8. Progression of Mitral Regurgitation Severity After Transcatheter Tricuspid Valve Replacement
   JACC Cardiovasc Interv. 2025 Jan 13:S1936-8798(24)01827-2. doi: 10.1016/j.jcin.2024.12.004. Online ahead of print. PMID: 39918500
   
   
9. Setting Benchmarks for Long-Term Success of Surgical Mitral Valve Repair in Reference Centers
   J Am Coll Cardiol. 2025 Jan 25:S0735-1097(24)10484-6. doi: 10.1016/j.jacc.2024.11.018. Online ahead of print. PMID: 39918473
   
   
10. Long-Term Outcomes of Contemporary Surgical Repair for Degenerative Mitral Regurgitation
    J Am Coll Cardiol. 2024 Dec 16:S0735-1097(24)10356-7. doi: 10.1016/j.jacc.2024.10.108. Online ahead of print.

View More

1. Aortic Annular Enlargement: Y-Incision Rationale, Technique, and Outcomes
   Ann Thorac Surg. 2025 Jan 30:S0003-4975(25)00083-9. doi: 10.1016/j.athoracsur.2025.01.016. Online ahead of print.
   
   
2. Coronary Events After Transcatheter Aortic Valve Replacement: Insights From the France TAVI Registry.
   JACC Cardiovasc Interv. 2025 Jan 27;18(2):229-243. doi: 10.1016/j.jcin.2024.09.005.
   
   
3. Passing the learning curve in robotic mitral valve repair-what do we know in 2025?
   Bonatti J. Eur J Cardiothorac Surg. 2025 Feb 4;67(2):ezaf012. doi: 10.1093/ejcts/ezaf012.
   
   
4. How the COAPT trial affected the selection of patients with secondary mitral regurgitation undergoing transcatheter edge-to-edge repair: insights from the GIOTTO Registry.
   Am Heart J. 2025 Jan 27:S0002-8703(25)00011-0. doi: 10.1016/j.ahj.2025.01.013. Online ahead of print.
   
   
5. Ross procedure for aortic regurgitation versus stenosis in adults with and without autograft support.
   Eur J Cardiothorac Surg. 2025 Jan 28:ezaf021. doi: 10.1093/ejcts/ezaf021. Online ahead of print.
   
   
6. Tricuspid regurgitation and outcomes in mitral valve transcatheter edge-to-edge repair.
   Eur Heart J. 2025 Jan 28:ehae924. doi: 10.1093/eurheartj/ehae924. Online ahead of print.
   
   
7. Aortic valve repair in adults: long-term clinical outcomes and echocardiographic evolution in different valve repair techniques.
   Eur J Cardiothorac Surg. 2025 Jan 28:ezaf020. doi: 10.1093/ejcts/ezaf020. Online ahead of print.
   
   
8. Outcomes of Combined Left Atrial Appendage Occlusion and Transcatheter Mitral Edge-to-Edge Repair: The WATCH-TEER Study.
   JACC Adv. 2025 Jan 8;4(2):101541. doi: 10.1016/j.jacadv.2024.101541. eCollection 2025 Feb.
   
   
9. Redo Surgical Aortic Valve Replacement versus Valve-in-Valve Transcatheter Aortic Valve Replacement for Degenerated Bioprosthetic Valves.
   Ann Thorac Surg. 2025 Jan 21:S0003-4975(25)00070-0. doi: 10.1016/j.athoracsur.2025.01.006. Online ahead of print.
   
   
10. A Contemporary Picture of Coagulase-Negative Staphylococcal Endocarditis: A Nationwide GAMES Cohort Study.
    J Am Coll Cardiol. 2025 Feb 4;85(4):305-318. doi: 10.1016/j.jacc.2024.09.027. Epub 2024 Nov 22.

View More

1. The optimal annual case volume for acute type A aortic dissection surgery in relation to long-term outcomes
   Eur J Cardiothorac Surg. 2025 Jan 25:ezaf022. doi: 10.1093/ejcts/ezaf022. Online ahead of print.
   
   
2. Outcomes and Predictors of Different Flow-Gradient Patterns of Aortic Stenosis Following Transcatheter Aortic Valve Replacement
   Am J Cardiol. 2025 Jan 22:S0002-9149(25)00045-1. doi: 10.1016/j.amjcard.2025.01.019. Online ahead of print.
   
   
3. Platform Selection for Patients Undergoing Transcatheter Aortic Valve Replacement: A Practical Approach
   Catheter Cardiovasc Interv. 2025 Jan 24. doi: 10.1002/ccd.31420. Online ahead of print.
   
   
4. Malperfusion in Patients with Acute Type A Aortic Dissection: A Nationwide Analysis
   Ann Thorac Surg. 2025 Jan 21:S0003-4975(25)00066-9. doi: 10.1016/j.athoracsur.2025.01.002. Online ahead of print.
   
   
5. Association with Outcome of the Regurgitant-Volume Adjusted Right Ventricular Ejection Fraction in Secondary Tricuspid Regurgitation
   J Am Soc Echocardiogr. 2025 Jan 21:S0894-7317(25)00039-2. doi: 10.1016/j.echo.2025.01.008. Online ahead of print.
   
   
6. Simplified Outcome Prediction in Patients Undergoing Transcatheter Tricuspid Valve Intervention by Survival Tree-Based Modelling
   JACC Adv. 2025 Jan 22;4(2):101575. doi: 10.1016/j.jacadv.2024.101575. Online ahead of print.
   
   
7. Novel Use of Intra-Aortic 3D ICE to Guide Ascending Aorta Pseudoaneurysm Repair
   JACC Cardiovasc Interv. 2025 Jan 2:S1936-8798(24)01733-3. doi: 10.1016/j.jcin.2024.11.022. Online ahead of print.
   
   
8. Plus Anchor Valve Replacement for Treatment of Severe Aortic Regurgitation With an Extremely Large Annulus
   JACC Cardiovasc Interv. 2024 Dec 21:S1936-8798(24)01741-2. doi: 10.1016/j.jcin.2024.11.030. Online ahead of print.
   
   
9. Paravalvular Leak Closure After Transcatheter Tricuspid Valve Replacement
   JACC Cardiovasc Interv. 2025 Jan 7:S1936-8798(24)01738-2. doi: 10.1016/j.jcin.2024.11.027. Online ahead of print.
   
   
10. Lifetime Management in Transcatheter Aortic Valve Replacement Through Patient-Specific Simulations
    JACC Cardiovasc Interv. 2025 Jan 16:S1936-8798(24)01734-5. doi: 10.1016/j.jcin.2024.11.023. Online ahead of print.
    
    

View More

1. Endo-Bentall Repair: Early Results and Feasibility of a Physician-Constructed Endo-Bentall Device
   A newer technique to treat high risk patients for surgery and if future trials support good outcomes can be very beneficial to this subset of patients who will have high surgical mortality.
   
   
2. Real-World Experience in Tricuspid Transcatheter Edge-to-Edge Repair: Transcatheter Tricuspid Valve Repair in Spain Registry
   Repair of severe TR associated with Left sided valve pathology plays a significant role in the immediate post op period in recovery and mortality. T-TEER is a welcome advancement in helping such patients non surgically with reasonably good results.
   
   
3. Prognostic Value of D-Dimer in Acute Type A Aortic Dissection and Intramural Hematoma: Observations from the Acute Aortic Syndrome Group of the Registry of Acute Non-Traumatic Chest Pain in China
   A useful parameter in calculating the prognosis after AAD/AIMH and should be included in the investigative workup for these two identities.
   
   
4. Valvular Heart Disease Care in Pakistan: Impact of the Multidisciplinary Valve Heart Team
   Heart Valve Team as always is welcome and should be part of treatment planning for all patients for individualized and customized treatment plans as has been seen in CABG group
   
   
5. Hemodynamic Valve Deterioration After Transcatheter Aortic Valve Replacement: Incidence, Predictors, and Clinical Outcomes
   An important study towards long term outcomes after TAVR. The known three entities in TAVR HALT requiring anticoagulation, AR or paravalvular leak going upto 25% after 10 years and PPI requirement makes SAVR a better treatment after 10 years as reintervention in such patients is 5 times.
   
   
6. Asymptomatic Severe Aortic-Valve Stenosis - To Wait or Not to Wait
   A dilemma discussed nicely as 50% of these patients are converted to TAVR/SAVR in one year time and another 25% in 6 years. So is there a rational of waiting risking LV dysfunction and stroke.
   
   
7. Management of Acute Coronary Syndrome in Patients With Transcatheter Aortic Valve Replacement: A Review
   An important identity as intervention in ACS after TAVR is challenging and carries high mortality so we need to dig deep to offer same quality treatment to non TAVr or TAVR patients with ACS though Conservative treatment remains the same as far as outcomes are concerned.
   
   
8. What Can be Done to Prevent Acute Renal Failure after Type A Aortic Dissection Repair?
   An important study to reduce the mortality and fasten recovery after this serious condition which otherwise carries a high mortality surgically if renal dysfunction sets in or severe PAH sets in.
   
   
9. Transcatheter versus Surgical Aortic Valve Replacement in Patients Younger than 65 Years in the US
   A very important study reflecting the strategy to treat younger patients weighing the pros and cons of both techniques, need for second intervention and its effects on longevity. Despite clinical guidelines, the utilization of TAVR has increased in patients <65. TAVR in this population is associated with a higher 6-year mortality and a higher rate of new permanent pacemaker implantation
   
   
10. Mitral Valve Repair Versus Replacement in Patients Undergoing Concomitant Aortic Valve Replacement
    An important review on a high risk surgery and repair performing better helps reduce CPB times and in turn reduces mortality, stroke and without increasing the risk of mitral valve reoperation.

View More

1. Prosthesis-Patient Mismatch in Patients With Bicuspid Aortic Valve
   JACC Cardiovasc Interv. 2024 Dec 20:S1936-8798(24)01522-X.doi: 10.1016/j.jcin.2024.10.038. Online ahead of print.
   
   
2. Impact of Intraprocedural Residual Mitral Regurgitation on Long-Term Survival: MITRA-PRO Registry 3-Year Follow-Up
   JACC Cardiovasc Interv. 2024 Dec 20:S1936-8798(24)01391-8.doi: 10.1016/j.jcin.2024.10.019. Online ahead of print.
   
   
3. "Diamond Capture" Technique for Degenerative Mitral Regurgitation With Large Flail Gap Using the PASCAL System
   JACC Cardiovasc Interv. 2024 Dec 20:S1936-8798(24)01380-3.doi: 10.1016/j.jcin.2024.10.010. Online ahead of print.
   
   
4. Incidence and Prognosis of Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement for Bicuspid Aortic Stenosis
   JACC Cardiovasc Interv. 2024 Dec 20:S1936-8798(24)01365-7.doi: 10.1016/j.jcin.2024.10.002. Online ahead of print.
   
   
5. Personalized management of tricuspid valve regurgitation
   Eur Heart J. 2025 Jan 11:ehae733.doi: 10.1093/eurheartj/ehae733. Online ahead of print.
   
   
6. Bacteraemia after transcatheter aortic valve implantation: a nationwide cohort study
   Heart. 2024 Dec 20:heartjnl-2024-324803.doi: 10.1136/heartjnl-2024-324803. Online ahead of print.
   
   
7. Delayed Aortic Dissection after TAVR for Stenotic Bicuspid Valve
   Am J Cardiol. 2025 Jan 8:S0002-9149(25)00006-2.doi: 10.1016/j.amjcard.2025.01.001. Online ahead of print.
   
   
8. Prognostic value of left atrioventricular coupling index in heart failure
   Eur Heart J Cardiovasc Imaging. 2025 Jan 10:jeaf010.doi: 10.1093/ehjci/jeaf010. Online ahead of print.
   
   
9. Prevalence, Etiology and Outcomes of Native Pulmonary Regurgitation in the General Adult Population
   Eur Heart J Cardiovasc Imaging. 2025 Jan 10:jeaf011.doi: 10.1093/ehjci/jeaf011. Online ahead of print.
   
   
10. Associations between central and brachial blood pressure in patients with hypertension and aortovascular disease: Implications for clinical practice: An analysis and review: Association between CBP and bBP
    Curr Probl Cardiol. 2025 Jan 7;50(3):102981.doi: 10.1016/j.cpcardiol.2025.102981. Online ahead of print.

View More

1. Outcomes and Impact of Device Iterations in Mitral Valve Transcatheter Edge-to-Edge Repair: The REPAIR Study
   JACC Cardiovasc Interv. 2024 Nov 25:S1936-8798(24)01712-6. doi: 10.1016/j.jcin.2024.11.016. Online ahead of print.
   
   
2. Temporal Improvement in Outcomes of Surgical Treatment of Isolated Tricuspid Regurgitation in the United States
   JACC Adv. 2024 Oct 10;3(11):101319.doi: 10.1016/j.jacadv.2024.101319. eCollection 2024 Nov.
   
   
3. Selecting the optimal candidates for percutaneous mitral valvuloplasty using multi-modality imaging
   Eur Heart J Cardiovasc Imaging. 2024 Dec 31:jeae334.doi: 10.1093/ehjci/jeae334. Online ahead of print.
   
   
4. Yearly Trends and In-Hospital Outcomes of Patients Undergoing Transcatheter Mitral Valve-In-Valve Replacement in Prosthetic Valve Dysfunction
   Catheter Cardiovasc Interv. 2025 Jan;105(1):239-248.doi: 10.1002/ccd.31345. Epub 2024 Dec 12.
   
   
5. Clinical Outcomes of Transcatheter Mitral Valve-In-Valve and Valve-In-Ring Implantation: A Systematic Review and Meta-Analysis
   Catheter Cardiovasc Interv. 2025 Jan;105(1):219-238.doi: 10.1002/ccd.31299. Epub 2024 Nov 20.
   
   
6. Accuracy of Three-Dimensional Neo Left Ventricular Outflow Tract Simulations With Transcatheter Mitral Valve Replacement in Different Mitral Phenotypes
   Catheter Cardiovasc Interv. 2025 Jan;105(1):249-257.doi: 10.1002/ccd.31287. Epub 2024 Nov 6.
   
   
7. Degenerative mitral stenosis by echocardiography: presentation and outcome
   Eur Heart J Cardiovasc Imaging. 2024 Dec 31;26(1):118-125.doi: 10.1093/ehjci/jeae246.
   
   
8. Implications of myocardial strain in primary mitral regurgitation-a cardiovascular magnetic resonance study
   Eur Heart J Cardiovasc Imaging. 2024 Dec 31;26(1):126-134.doi: 10.1093/ehjci/jeae245.
   
   
9. The prevalence, aetiologies, and clinical consequences of tricuspid regurgitation associated with severe degenerative mitral regurgitation
   Eur Heart J Cardiovasc Imaging. 2024 Dec 31;26(1):150-160.doi: 10.1093/ehjci/jeae229.
   
   
10. Mitral regurgitation evolution after transcatheter tricuspid valve interventions-a sub-analysis of the TriValve registry
    Eur Heart J Cardiovasc Imaging. 2024 Dec 31;26(1):135-147.doi: 10.1093/ehjci/jeae227.

View More

1. Transcatheter Approaches to Atrial Functional Mitral Regurgitation: How Far Have We Come?
   Catheter Cardiovasc Interv. 2024 Dec 26. doi: 10.1002/ccd.31368.
   
   
2. Gender Differences in Acute Type A Aortic Dissection: A Comprehensive Review and Meta-Analysis.
   Am J Cardiol. 2024 Dec 23:S0002-9149(24)00880-4. doi: 10.1016/j.amjcard.2024.12.023.
   
   
3. End of Life After Transcatheter Aortic Valve Replacement: A Danish Nationwide Cohort Study.
   JACC Cardiovasc Interv. 2024 Dec 23;17(24):2936-2946. doi: 10.1016/j.jcin.2024.09.021.
   
   
4. Femoral or Radial Secondary Access in TAVR: A Subanalysis From the Multicenter PULSE Registry.
   JACC Cardiovasc Interv. 2024 Dec 23;17(24):2923-2932. doi: 10.1016/j.jcin.2024.09.020.
   
   
5. New wearable cardiac acoustic monitoring technology for evaluation of subclinical leaflet thrombosis after transcatheter aortic valve replacement.
   Heart. 2024 Dec 25:heartjnl-2024-324698. doi: 10.1136/heartjnl-2024-324698.
   
   
6. Days at Home After Transcatheter Mitral Valve Repair Versus Medical Therapy Alone in Heart Failure.
   J Am Heart Assoc. 2024 Dec 24:e038401. doi: 10.1161/JAHA.124.038401.
   
   
7. Comparative Analysis of Central and Noncentral Degenerative Mitral Regurgitation Treated With Transcatheter Mitral Valve Edge-To-Edge Repair.
   Catheter Cardiovasc Interv. 2024 Dec 24. doi: 10.1002/ccd.31359.
   
   
8. Classification of primary mitral regurgitation using extramitral cardiac involvement in patients undergoing transcatheter edge-to-edge repair.
   Catheter Cardiovasc Interv. 2024 Dec;104(7):1479-1490. doi: 10.1002/ccd.31253. Epub 2024 Oct 31.
   
   
9. Management of iatrogenic ascending aortic dissection after percutaneous intervention of chronic total occlusion.
   Catheter Cardiovasc Interv. 2024 Dec;104(7):1442-1446. doi: 10.1002/ccd.31262. Epub 2024 Oct 9.
   
   
10. Transcatheter Aortic Valve Implantation in Small and Very Small Aortic Valve Annuli: A Propensity-Matched Analysis Between Self-Expanding Versus Balloon-Expandable Valves.
    Catheter Cardiovasc Interv. 2024 Dec 24. doi: 10.1002/ccd.31374.

View More

1. Chronobiological Patterns and Risk of Acute Aortic Dissection: A Clinical Retrospective and Two-Sample Mendelian Randomisation Study
   
   
2. Low-Gradient Severe Aortic Stenosis Is Not Mainstream: Insights From the CURRENT AS Registry-2
   
   
3. Early Outcomes of Transjugular Transcatheter Tricuspid Valve Replacement
   
   
4. "T-Clipping" for Transcutaneous Edge-to-Edge Repair of Mitral Regurgitation Resulting From a Cleftlike Indentation
   
   
5. Unavoidable Iatrogenic Mitral Stenosis Following Transcatheter Edge-to-Edge Mitral Valve Repair With Current Devices
   
   
6. Low-Gradient Severe Aortic Stenosis: Insights From the CURRENT AS Registry-2
   
   
7. Association of Preoperative Oxygen Saturation and McGoon Ratio With Early Prognosis of Tetralogy of Fallot: A Propensity Score-Matched Analysis
   
   
8. Mortality associated with moderate and severe mitral regurgitation in 608 570 men and women undergoing echocardiography
   
   
9. Structural Heart Disease in the Tropics: A Comprehensive Review
   
   
10. Safety of prolonged bilateral antegrade cerebral perfusion in aortic arch surgery with moderate hypothermia

View More

1. Transcatheter Aortic Valve Implantation Failure: Critique and Future Directions
   
   
2. Deferral of routine percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation: rationale and design of the PRO-TAVI trial: the PRO-TAVI trial: rationale and design
   
   
3. Commentary: Reoperative aortic root replacement - further evidence of feasibility….. and expertise still matters
   
   
4. Enhanced recovery after minimally invasive cardiac surgery following a zero ICU concept-a propensity score-matched analysis
   
   
5. Long-term results of edge-to-edge and neochordal mitral repair for isolated anterior leaflet lesion: a propensity match analysis
   
   
6. Comparison between Duke, ESC-2015, ISCVID-2023 and ESC-2023 criteria for the diagnosis of TAVR-related infective endocarditis
   
   
7. Global, Regional, and National Burden of Valvular Heart Disease, 1990 to 2021
   
   
8. Post-implant transcatheter aortic prosthesis deformation: tricuspid versus bicuspid valve
   
   
9. Perioperative and long-term outcomes of bilateral cardiac sympathetic denervation via video-assisted thoracoscopic surgery in patients with refractory ventricular arrhythmias
   
   
10. Atrial and ventricular functional mitral regurgitation: prevalence, characteristics, outcomes, and disease progression

View More

1. TransCatheter aortic valve implantation and fractional flow reserve-guided percutaneous coronary intervention versus conventional surgical aortic valve replacement and coronary bypass grafting for treatment of patients with aortic valve stenosis and complex or multivessel coronary disease (TCW): an international, multicentre, prospective, open-label, non-inferiority, randomised controlled trial
   
   
2. TAVI and PCI: redefining treatment for aortic stenosis and complex coronary artery disease
   
   
3. Clinical Course and Outcomes of Acute Heart Failure with Moderate-to-Severe Mitral or Tricuspid Regurgitation: Decongestion in Heart Failure with Atrioventricular Valve Regurgitation
   
   
4. Are there sex-specific disparities in transcatheter aortic valve implantation?
   
   
5. Aortic Valve Replacement vs Clinical Surveillance in Asymptomatic Severe Aortic Stenosis: A Systematic Review and Meta-Analysis
   
   
6. Left Ventricular Hypertrophy in Aortic Stenosis: Early Cell and Matrix Regression 2 Months Post-Aortic Valve Replacement
   
   
7. Depression in Patients With Symptomatic Aortic Stenosis Predicts 3-Year Mortality After Transcatheter Aortic Valve Implantation
   
   
8. Midterm Survival, Clinical, and Hemodynamic Outcomes of a Novel Mechanical Mitral Valve Prosthesis
   
   
9. Implications of Tricuspid Regurgitation Severity in Patients Undergoing Mitral Transcatheter Edge-to-Edge Repair
   
   
10. Hospitalization of Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation Treated With MitraClip: Insights From RESHAPE-HF2

View More

1. Right ventricular to pulmonary arterial coupling as a predictor of survival in patients undergoing mitral valve surgery for mitral regurgitation
   
   
2. Availability of transcatheter aortic valve implantation across hospitals and differences in strategies and clinical outcomes in patients with severe aortic stenosis
   
   
3. Surgical and transcatheter aortic valve interventions for aortic stenosis in England: sociodemographic variations in treatment trends and outcome over 20 years
   
   
4. Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement: Lower the Guard or Stay Alert?
   
   
5. Impact of Measured and Predicted Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Replacement
   
   
6. Valve Performance Between Latest-Generation Balloon-Expandable and Self-Expandable Transcatheter Heart Valves in a Small Aortic Annulus
   
   
7. Mechanisms of repair failure after mitral valve repair using chordal replacement
   
   
8. Long-term outcomes in total arch replacement combined with frozen elephant trunk for acute type A aortic dissection
   
   
9. All-cause mortality and death by aortic dissection in women with Turner syndrome: a national clinical cohort study
   
   
10. The transaxillary concept for minimally invasive isolated aortic valve replacement: results of 1,000 consecutive patients

View More

1. Association Between Direct Oral Anticoagulant Score and Bleeding Events in Patients With Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: A Retrospective Multicenter Cohort Study
   J Am Heart Assoc. 2024 Nov 19;13(22):e036417. doi: 10.1161/JAHA.124.036417. Epub 2024 Nov 7.
   
   
2. Empagliflozin Attenuates Neointima Formation After Arterial Injury and Inhibits Smooth Muscle Cell Proliferation and Migration by Suppressing Platelet-Derived Growth Factor-Related Signaling
   J Am Heart Assoc. 2024 Nov 19;13(22):e035044. doi: 10.1161/JAHA.124.035044. Epub 2024 Nov 7.
   
   
3. Accuracy of Three-Dimensional Neo Left Ventricular Outflow Tract Simulations With Transcatheter Mitral Valve Replacement in Different Mitral Phenotypes
   J Am Heart Assoc. 2024 Nov 19;13(22):e035044. doi: 10.1161/JAHA.124.035044. Epub 2024 Nov 7.
   
   
4. Dobutamine in low-flow, low-gradient severe aortic stenosis with preserved ejection fraction: Is exercise testing the key? - Authors' reply
   J Am Soc Echocardiogr. 2024 Nov 4:S0894-7317(24)00559-5. doi: 10.1016/j.echo.2024.10.013. Online ahead of print.
   
   
5. Transcatheter aortic-valve implantation with or without on-site cardiac surgery: The TRACS trial
   J Am Soc Echocardiogr. 2024 Nov 4:S0894-7317(24)00559-5. doi: 10.1016/j.echo.2024.10.013. Online ahead of print.
   
   
6. Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease
   JAMA Cardiol. 2024 Nov 6:e243738. doi: 10.1001/jamacardio.2024.3738. Online ahead of print.
   
   
7. The Role of Fat in Frailty Assessment Before Transcatheter Aortic Valve Replacement
   JAMA Cardiol. 2024 Nov 6. doi: 10.1001/jamacardio.2024.3822. Online ahead of print.
   
   
8. Disease Drivers in Aortic Stenosis vs Atherosclerosis
   JAMA Cardiol. 2024 Nov 6. doi: 10.1001/jamacardio.2024.3749. Online ahead of print.
   
   
9. Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation
   JAMA Cardiol. 2024 Nov 6. doi: 10.1001/jamacardio.2024.3749. Online ahead of print.
   
   
10. Screening for Abdominal Aortic Aneurysms Still Prevents Ruptures: A Secondary Analysis of the VIVA Trial
    J Am Coll Cardiol. 2024 Oct 22:S0735-1097(24)08463-8. doi: 10.1016/j.jacc.2024.09.011. Online ahead of print.

View More

1. Unilateral-access vs. bilateral-access in transfemoral transcatheter aortic valve replacement: A slim fit approach
   Int J Cardiol. 2024 Nov 14:132712. doi: 10.1016/j.ijcard.2024.132712. Online ahead of print.
   
   
2. Clinical Outcomes According to Aortic Stenosis Management: Insights From Real-World Practice
   Int J Cardiol. 2024 Nov 14:132712. doi: 10.1016/j.ijcard.2024.132712. Online ahead of print.
   
   
3. Commentator Discussion: The impact of blood type and body size on successful bridging to heart transplantation using intra-aortic balloon pump or surgically implanted microaxial left ventricular assist device
   J Thorac Cardiovasc Surg. 2024 Nov 12:S0022-5223(24)00922-X. doi: 10.1016/j.jtcvs.2024.10.013. Online ahead of print.
   
   
4. Calcific Aortic Valve Disease: Lp(a) Takes the Heat, But Is OxPL Really Fanning the Flames?
   J Am Coll Cardiol. 2024 Nov 6:S0735-1097(24)10048-4. doi: 10.1016/j.jacc.2024.09.1240. Online ahead of print.
   
   
5. Oxidized Phospholipids and Calcific Aortic Valvular Disease
   J Am Coll Cardiol. 2024 Nov 6:S0735-1097(24)10048-4. doi: 10.1016/j.jacc.2024.09.1240. Online ahead of print.
   
   
6. Echocardiographic Evaluation of Chronic Aortic Regurgitation: Comparison With Cardiac Magnetic Resonance and Implications for Guideline Recommendations
   JACC Cardiovasc Imaging. 2024 Oct 30:S1936-878X(24)00390-5. doi: 10.1016/j.jcmg.2024.08.013. Online ahead of print.
   
   
7. Echocardiographic Markers of Early Left Ventricular Dysfunction in Asymptomatic Aortic Regurgitation: Is It Time to Change the Guidelines?
   JACC Cardiovasc Imaging. 2024 Oct 29:S1936-878X(24)00392-9. doi: 10.1016/j.jcmg.2024.09.005. Online ahead of print.
   
   
8. Definitions of clinical study outcome measures for cardiovascular diseases: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
   Eur Heart J. 2024 Nov 15:ehae724. doi: 10.1093/eurheartj/ehae724. Online ahead of print.
   
   
9. Impact of Moderate or Severe Mitral and Tricuspid Valves Regurgitation after Transcatheter Aortic Valve Replacement
   Am Heart J. 2024 Nov 12:S0002-8703(24)00295-3. doi: 10.1016/j.ahj.2024.11.003. Online ahead of print.
   
   
10. Optimizing ring selection for secondary tricuspid regurgitation: the role of body size
    Eur J Cardiothorac Surg. 2024 Nov 14:ezae407. doi: 10.1093/ejcts/ezae407. Online ahead of print.

View More

1. Association Between Direct Oral Anticoagulant Score and Bleeding Events in Patients With Atrial Fibrillation Following Transcatheter Aortic Valve Replacement: A Retrospective Multicenter Cohort Study
   J Am Heart Assoc. 2024 Nov 7:e036417. doi: 10.1161/JAHA.124.036417. Online ahead of print.
   
   
2. Empagliflozin Attenuates Neointima Formation After Arterial Injury and Inhibits Smooth Muscle Cell Proliferation and Migration by Suppressing Platelet-Derived Growth Factor-Related Signaling
   J Am Heart Assoc. 2024 Nov 7:e035044. doi: 10.1161/JAHA.124.035044. Online ahead of print.
   
   
3. Accuracy of Three-Dimensional Neo Left Ventricular Outflow Tract Simulations With Transcatheter Mitral Valve Replacement in Different Mitral Phenotypes
   J Am Heart Assoc. 2024 Nov 7:e035044. doi: 10.1161/JAHA.124.035044. Online ahead of print.
   
   
4. Dobutamine in low-flow, low-gradient severe aortic stenosis with preserved ejection fraction: Is exercise testing the key? - Authors' reply
   J Am Soc Echocardiogr. 2024 Nov 4:S0894-7317(24)00559-5. doi: 10.1016/j.echo.2024.10.013. Online ahead of print.
   
   
5. TRanscatheter Aortic-Valve Implantation with or without on-site Cardiac Surgery: the TRACS trial: TAVI in centers without on-site cardiac surgery
   Am Heart J. 2024 Nov 4:S0002-8703(24)00281-3. doi: 10.1016/j.ahj.2024.10.019. Online ahead of print.
   
   
6. Distinct Genetic Risk Profile in Aortic Stenosis Compared With Coronary Artery Disease
   JAMA Cardiol. 2024 Nov 6. doi: 10.1001/jamacardio.2024.3738. Online ahead of print.
   
   
7. The Role of Fat in Frailty Assessment Before Transcatheter Aortic Valve Replacement
   JAMA Cardiol. 2024 Nov 6. doi: 10.1001/jamacardio.2024.3822. Online ahead of print.
   
   
8. Disease Drivers in Aortic Stenosis vs Atherosclerosis
   JAMA Cardiol. 2024 Nov 6. doi: 10.1001/jamacardio.2024.3749. Online ahead of print.
   
   
9. Prevalence of HFpEF in Isolated Severe Secondary Tricuspid Regurgitation
   JAMA Cardiol. 2024 Nov 6. doi: 10.1001/jamacardio.2024.3767. Online ahead of print.
   
   
10. Screening for Abdominal Aortic Aneurysms Still Prevents Ruptures: A Secondary Analysis of the VIVA Trial
    J Am Coll Cardiol. 2024 Oct 22:S0735-1097(24)08463-8. doi: 10.1016/j.jacc.2024.09.011. Online ahead of print.
    
    

View More

1. Dobutamine in low-flow, low-gradient severe aortic stenosis with preserved ejection fraction: Is exercise testing the key?
   J Am Soc Echocardiogr. 2024 Oct 31:S0894-7317(24)00558-3. doi: 10.1016/j.echo.2024.09.015. Online ahead of print.
   
   
2. Determination of Inoue Balloon Size by Analysis of Mitral Valve Geometry Using Three-Dimensional Transesophageal Echocardiography in Patients with Mitral Stenosis
   Am J Cardiol. 2024 Oct 30:S0002-9149(24)00771-9. doi: 10.1016/j.amjcard.2024.10.031. Online ahead of print.
   
   
3. Mortality Based Right Ventricle Functional Echocardiographic Cutoffs in Patients With Compared to Without Tricuspid Regurgitation
   J Am Soc Echocardiogr. 2024 Oct 30:S0894-7317(24)00557-1. doi: 10.1016/j.echo.2024.10.012. Online ahead of print.
   
   
4. Beyond Prognosis: The Vital Role of Quality of Life after Transcatheter Tricuspid Valve Replacement
   J Am Soc Echocardiogr. 2024 Oct 30:S0894-7317(24)00557-1. doi: 10.1016/j.echo.2024.10.012. Online ahead of print.
   
   
5. Advances in Transcatheter Tricuspid Valve Interventions-Implications for Health Policy
   J Am Coll Cardiol. 2024 Oct 21:S0735-1097(24)10057-5. doi: 10.1016/j.jacc.2024.10.089. Online ahead of print.
   
   
6. Transcatheter Interventions in Tricuspid Regurgitation: Shifting the focus beyond Quantity of Life to Quality of Life
   J Am Coll Cardiol. 2024 Oct 18:S0735-1097(24)10053-8. doi: 10.1016/j.jacc.2024.10.085. Online ahead of print.
   
   
7. Ascending aortic length predicts adverse outcomes in type a intramural hematoma
   Eur J Cardiothorac Surg. 2024 Nov 1:ezae386. doi: 10.1093/ejcts/ezae386. Online ahead of print.
   
   
8. Aortic arch replacement in patients with previous repair of acute aortic dissection: a systematic review and meta-analysis
   Eur J Cardiothorac Surg. 2024 Nov 1:ezae396. doi: 10.1093/ejcts/ezae396. Online ahead of print.
   
   
9. Classification of primary mitral regurgitation using extramitral cardiac involvement in patients undergoing transcatheter edge-to-edge repair
   Catheter Cardiovasc Interv. 2024 Oct 31. doi: 10.1002/ccd.31253. Online ahead of print.
   
   
10. Robotic Aortic Valve Replacement versus Transcatheter Aortic Valve Replacement: A Propensity Matched Analysis
    Ann Thorac Surg. 2024 Oct 29:S0003-4975(24)00921-4. doi: 10.1016/j.athoracsur.2024.10.013. Online ahead of print.

View More

1. Luminal shape and aortic remodelling after total arch replacement for type A aortic dissection: conventional and frozen elephant trunks
   Eur J Cardiothorac Surg. 2024 Oct 26:ezae375. doi: 10.1093/ejcts/ezae375. Online ahead of print.
   
   
2. An Early Experience Using a Hybrid Graft for Aortic Arch Dissection
   Am J Cardiol. 2024 Oct 23:S0002-9149(24)00736-7. doi: 10.1016/j.amjcard.2024.10.013. Online ahead of print.
   
   
3. Symptoms of Anxiety and Depression in Patients Undergoing Transcatheter Aortic Valve Implantation - The SAD-TAVI Study
   Am J Cardiol. 2024 Oct 23:S0002-9149(24)00735-5. doi: 10.1016/j.amjcard.2024.10.007. Online ahead of print.
   
   
4. National Costs for Cardiovascular-related Hospitalizations and Inpatient Procedures in the United States, 2016-2021
   Am J Cardiol. 2024 Oct 23:S0002-9149(24)00729-X. doi: 10.1016/j.amjcard.2024.10.003. Online ahead of print.
   
   
5. Assessment of Genetic Variants Linked to Susceptibility to Mechanical Prosthetic Valve Thrombosis
   Am J Cardiol. 2024 Oct 23:S0002-9149(24)00739-2. doi: 10.1016/j.amjcard.2024.10.014. Online ahead of print.
   
   
6. Comparison between invasive cardiac output and left ventricular assist device flow parameter
   Eur J Cardiothorac Surg. 2024 Oct 25:ezae383. doi: 10.1093/ejcts/ezae383. Online ahead of print.
   
   
7. Lifetime Management of Aortic Stenosis: Initial TAVR Device Selection Matters
   JACC Cardiovasc Interv. 2024 Sep 27:S1936-8798(24)01110-5. doi: 10.1016/j.jcin.2024.08.023. Online ahead of print.
   
   
8. It Is Time to Tighten the Screws!
   JACC Cardiovasc Interv. 2024 Sep 27:S1936-8798(24)01110-5. doi: 10.1016/j.jcin.2024.08.023. Online ahead of print.
   
   
9. Combined Impact of Residual Mitral Regurgitation and Gradient After Mitral Valve Transcatheter Edge-to-Edge Repair
   JACC Cardiovasc Interv. 2024 Sep 27:S1936-8798(24)01110-5. doi: 10.1016/j.jcin.2024.08.023. Online ahead of print.
   
   
10. TAVR-in-TAVR for Early Degeneration of a Novel Self-Expandable Valve Dedicated to Treatment of Aortic Regurgitation
    JACC Cardiovasc Interv. 2024 Sep 13:S1936-8798(24)01102-6. doi: 10.1016/j.jcin.2024.08.015. Online ahead of print.

View More

1. Factors Associated with Permanent Pacemaker Placement After Tricuspid Valve Operations
   Ann Thorac Surg. 2024 Oct 17:S0003-4975(24)00862-2. doi: 10.1016/j.athoracsur.2024.09.042. Online ahead of print.
   
   
2. The treatment of type A aortic dissection is not done once and for all: Time to focus on residual aortic dissection
   J Thorac Cardiovasc Surg. 2024 Oct 16:S0022-5223(24)00832-8. doi: 10.1016/j.jtcvs.2024.09.025. Online ahead of print.
   
   
3. Mitral Annular Disjunction in Heritable Thoracic Aortic Disease: Insights From the Montalcino Aortic Consortium
   J Am Heart Assoc. 2024 Oct 18:e036274. doi: 10.1161/JAHA.124.036274. Online ahead of print.
   
   
4. Trends in Transcatheter Versus Surgical Aortic Valve Replacement Outcomes in Patients With Low-Surgical Risk: A Systematic Review and Meta-Analysis of Randomized Trials
   J Am Heart Assoc. 2024 Oct 18:e036179. doi: 10.1161/JAHA.124.036179. Online ahead of print.
   
   
5. Lipoprotein(a) and High-Sensitivity C-Reactive Protein Compound the Risk of Hypoattenuating Leaflet Thickening After Transcatheter Aortic Valve Replacement
   J Am Heart Assoc. 2024 Oct 18:e035597. doi: 10.1161/JAHA.124.035597. Online ahead of print.
   
   
6. The Critical Role of Mitral Regurgitation Etiology in TAVR
   Ann Thorac Surg. 2024 Oct 16:S0003-4975(24)00867-1. doi: 10.1016/j.athoracsur.2024.09.047. Online ahead of print.
   
   
7. Aortic Valve Neocuspidization: An Additional Asset in the Lifetime Management of Aortic Valve Diseases
   Ann Thorac Surg. 2024 Oct 16:S0003-4975(24)00865-8. doi: 10.1016/j.athoracsur.2024.09.045. Online ahead of print.
   
   
8. RATE OF ASCENDING AORTIC ENLARGEMENT IN A LARGE ECHOCARDIOGRAPHIC COHORT: ASSOCIATED RISK FACTORS AND ADVERSE AORTIC EVENTS
   J Am Soc Echocardiogr. 2024 Oct 16:S0894-7317(24)00506-6. doi: 10.1016/j.echo.2024.09.013. Online ahead of print.
   
   
9. Rare cause of hematemesis after aortic stent graft implantation: dissection false lumen infection leading to esophageal fistula
   Eur Heart J Cardiovasc Imaging. 2024 Oct 18:jeae268. doi: 10.1093/ehjci/jeae268. Online ahead of print.
   
   
10. When One Day Becomes Today
    Eur Heart J Cardiovasc Imaging. 2024 Oct 18:jeae268. doi: 10.1093/ehjci/jeae268. Online ahead of print.

View More

1. Methylprednisolone for acute type A aortic dissection patients undergoing total arch replacement: Design and rationale of the Medal trial: Short title Study protocol of the Medal trial
   Am Heart J. 2024 Oct 10:S0002-8703(24)00265-5. doi: 10.1016/j.ahj.2024.10.003. Online ahead of print.
   
   
2. Outcomes of the Modified Warden Procedure for Partial Anomalous Pulmonary Venous Connection Drainage to a High Location in the Superior Vena Cava
   Heart Lung Circ. 2024 Oct 10:S1443-9506(24)01758-X. doi: 10.1016/j.hlc.2024.06.1038. Online ahead of print.
   
   
3. Reply to Pradegan et al
   Eur J Cardiothorac Surg. 2024 Oct 11:ezae359. doi: 10.1093/ejcts/ezae359. Online ahead of print.
   
   
4. Weekly Journal Scan: is MATTERHORN a game changer for secondary mitral regurgitation? Still climbing
   Eur Heart J. 2024 Oct 11:ehae650. doi: 10.1093/eurheartj/ehae650. Online ahead of print.
   
   
5. Baseline Diameter Does Not Predict Growth Rate in a Presurgical Ascending Thoracic Aortic Aneurysm Population
   J Am Heart Assoc. 2024 Oct 11:e036896. doi: 10.1161/JAHA.124.036896. Online ahead of print.
   
   
6. Burden and Temporal Trends of Valvular Heart Disease-Related Heart Failure From 1990 to 2019 and Projection Up to 2030 in Group of 20 Countries: An Analysis for the Global Burden of Disease Study 2019
   J Am Heart Assoc. 2024 Oct 11:e036462. doi: 10.1161/JAHA.124.036462. Online ahead of print.
   
   
7. Outcomes of Watchful Waiting Strategy and Predictors of Postoperative Prognosis in Asymptomatic or Equivocally Symptomatic Chronic Severe Aortic Regurgitation With Preserved Left Ventricular Function
   J Am Heart Assoc. 2024 Oct 11:e036292. doi: 10.1161/JAHA.124.036292. Online ahead of print.
   
   
8. Association Between Body Mass Index and Risk of Aortic Stenosis in Women in the Swedish Medical Birth Registry
   J Am Heart Assoc. 2024 Oct 11:e034891. doi: 10.1161/JAHA.123.034891. Online ahead of print.
   
   
9. Treating Aortic Stenosis in Young Patients
   JACC Adv. 2024 Sep 27;3(11):101311. doi: 10.1016/j.jacadv.2024.101311. eCollection 2024 Nov.
   
   
10. Impact of Hospital Transfers on Cardiac Surgery Outcomes: A Society of Thoracic Surgeons Adult Cardiac Surgery Database Analysis
    Ann Thorac Surg. 2024 Oct 8:S0003-4975(24)00841-5. doi: 10.1016/j.athoracsur.2024.09.033. Online ahead of print.

View More

1. Atrial Fibrillation Surgery in Australia: Are We Doing Enough?
   Heart Lung Circ. 2024 Oct 3:S1443-9506(24)01735-9. doi: 10.1016/j.hlc.2024.07.007. Online ahead of print.
   
   
2. Clinical and echocardiographic parameters associated with outcomes in patients with moderate secondary mitral regurgitation
   Heart. 2024 Oct 4:heartjnl-2024-324526. doi: 10.1136/heartjnl-2024-324526. Online ahead of print.
   
   
3. Development of a Novel Society of Thoracic Surgeons Aortic Surgery Mortality and Morbidity Risk Model
   Ann Thorac Surg. 2024 Oct 2:S0003-4975(24)00833-6. doi: 10.1016/j.athoracsur.2024.09.025. Online ahead of print.
   
   
4. Evaluation of the clinical features of an outpatient cohort with Marfan syndrome
   Int J Cardiol. 2024 Oct 2:132604. doi: 10.1016/j.ijcard.2024.132604. Online ahead of print.
   
   
5. Commentary: Exploring hemodynamic mechanisms and re-intervention strategies for partial false lumen thrombosis in Stanford type B aortic dissection after thoracic aortic endovascular repair
   Int J Cardiol. 2024 Oct 2:132607. doi: 10.1016/j.ijcard.2024.132607. Online ahead of print.
   
   
6. Surgical Redo Mitral Replacement Compared to Transcatheter Valve-in-Valve in the Mitral Position
   J Thorac Cardiovasc Surg. 2024 Oct 2:S0022-5223(24)00901-2. doi: 10.1016/j.jtcvs.2024.09.048. Online ahead of print.
   
   
7. Initial Balloon Versus Surgical Valvuloplasty In Children With Isolated Congenital Aortic Stenosis: Impact On Timing Of Aortic Valve Replacement
   J Thorac Cardiovasc Surg. 2024 Oct 2:S0022-5223(24)00896-1. doi: 10.1016/j.jtcvs.2024.09.043. Online ahead of print.
   
   
8. Urgent hybrid repair of a symptomatic dissection-related type ii thoracoabdominal aortic aneurysms
   Eur J Cardiothorac Surg. 2024 Oct 4:ezae361. doi: 10.1093/ejcts/ezae361. Online ahead of print.
   
   
9. Closed-chest robotic mitral repair using a semi-rigid ring inserted through a trocar
   Eur J Cardiothorac Surg. 2024 Oct 4:ezae362. doi: 10.1093/ejcts/ezae362. Online ahead of print.
   
   
10. The Continuity Equation is Superior to the Pressure Half-time Method in Calcific Mitral Stenosis: A Comparison with Cardiac Catheterization
    Eur Heart J Cardiovasc Imaging. 2024 Oct 4:jeae253. doi: 10.1093/ehjci/jeae253. Online ahead of print.

View More

1. Elevated myocardial extracellular volume fraction as a new predictor of conduction defects after transcatheter aortic valve replacement
   Catheter Cardiovasc Interv. 2024 Sep 29. doi: 10.1002/ccd.31252. Online ahead of print.
   
   
2. Redo surgical aortic valve replacement for bioprosthetic structural valve deterioration
   Eur J Cardiothorac Surg. 2024 Sep 28:ezae353. doi: 10.1093/ejcts/ezae353. Online ahead of print.
   
   
3. Plea for an In-Depth Analysis of the RESHAPE-HF2 Results
   J Am Coll Cardiol. 2024 Aug 31:S0735-1097(24)08236-6. doi: 10.1016/j.jacc.2024.08.030. Online ahead of print.
   
   
4. Diffuse Interstitial Fibrosis of the Myocardium Predicts Outcome in Moderate and Asymptomatic Severe Aortic Stenosis
   JACC Cardiovasc Imaging. 2024 Sep 10:S1936-878X(24)00343-7. doi: 10.1016/j.jcmg.2024.08.003. Online ahead of print.
   
   
5. The Impact of Blood Type and Body Size on Successful Bridging to Heart Transplantation using Intraaortic Balloon Pump or Surgically Implanted Microaxial Left Ventricular Assist Device
   J Thorac Cardiovasc Surg. 2024 Sep 25:S0022-5223(24)00835-3. doi: 10.1016/j.jtcvs.2024.09.028. Online ahead of print.
   
   
6. Left Ventricular Hypertrophy Regression Following Transcatheter Aortic Replacement: A Comparison of Self-Expanding Versus Balloon-Expandable Prostheses
   Am J Cardiol. 2024 Sep 25:S0002-9149(24)00697-0. doi: 10.1016/j.amjcard.2024.09.019. Online ahead of print.
   
   
7. Corrigendum to: Impact of explanted valve type on aortic valve reoperations: nationwide UK experience
   Eur J Cardiothorac Surg. 2024 Sep 2;66(3):ezae340. doi: 10.1093/ejcts/ezae340.
   
   
8. Artificial intelligence enhanced strategies for reducing mortality in transcatheter aortic valve replacement: improving outcomes and minimizing risks
   Eur J Cardiothorac Surg. 2024 Sep 27:ezae357. doi: 10.1093/ejcts/ezae357. Online ahead of print.
   
   
9. The Intra-Aortic Balloon Pump as a Rescue Device: Do we need to shift our strategy for cardiogenic shock rescue after cardiac surgery?
   J Thorac Cardiovasc Surg. 2024 Sep 24:S0022-5223(24)00836-5. doi: 10.1016/j.jtcvs.2024.09.029. Online ahead of print.
   
   
10. Elective Root Replacement Increases the Risk of Type B Dissection in Patients with Marfan Syndrome
    J Thorac Cardiovasc Surg. 2024 Sep 24:S0022-5223(24)00834-1. doi: 10.1016/j.jtcvs.2024.09.027. Online ahead of print.

View More

1. Complex Bentall Operation: Clinical Pearls to Standardize the Procedure
   Ann Thorac Surg. 2024 Sep 19:S0003-4975(24)00778-1. doi: 10.1016/j.athoracsur.2024.09.013. Online ahead of print.
   
   
2. Late diagnosis of Marfan syndrome is associated with unplanned aortic surgery and cardiovascular death
   J Thorac Cardiovasc Surg. 2024 Sep 19:S0022-5223(24)00814-6. doi: 10.1016/j.jtcvs.2024.09.016. Online ahead of print.
   
   
3. Infective Endocarditis Involving Bicuspid Aortic Valve, Native and Post-Aortic Valve Replacement (AVR): A Word of Caution!
   Heart Lung Circ. 2024 Oct;33(10):1381-1382. doi: 10.1016/j.hlc.2024.09.003.
   
   
4. 3D Transthoracic Echocardiography for Semiautomated Analysis of the Tricuspid Annulus: Validation and Normal Values
   J Am Soc Echocardiogr. 2024 Sep 18:S0894-7317(24)00453-X. doi: 10.1016/j.echo.2024.09.007. Online ahead of print.
   
   
5. Enhanced machine learning models for predicting one-year mortality in individuals suffering from type A aortic dissection
   J Thorac Cardiovasc Surg. 2024 Sep 18:S0022-5223(24)00817-1. doi: 10.1016/j.jtcvs.2024.09.019. Online ahead of print.
   
   
6. CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry
   Int J Cardiol. 2024 Sep 18:132569. doi: 10.1016/j.ijcard.2024.132569. Online ahead of print.
   
   
7. Degenerative Mitral Stenosis by echocardiography: presentation and outcome
   Eur Heart J Cardiovasc Imaging. 2024 Sep 20:jeae246. doi: 10.1093/ehjci/jeae246. Online ahead of print.
   
   
8. Iatrogenic atrial septal defects in structural heart interventions: Opening the Pandora's box
   Catheter Cardiovasc Interv. 2024 Sep 19. doi: 10.1002/ccd.31237. Online ahead of print.
   
   
9. THE AREAS AND GRADIENTS IN RHEUMATIC MITRAL STENOSIS: A TALE OF HIGHS AND LOWS
   J Am Soc Echocardiogr. 2024 Sep 17:S0894-7317(24)00450-4. doi: 10.1016/j.echo.2024.09.004. Online ahead of print.
   
   
10. A Novel Echocardiography Feature-Tracking Algorithm for Stabilized Frame-to-Frame Extraction of Aortic Root Diameters in the Parasternal Long Axis
    J Am Soc Echocardiogr. 2024 Sep 17:S0894-7317(24)00451-6. doi: 10.1016/j.echo.2024.09.005. Online ahead of print.

View More

1. Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI
   Int J Cardiol. 2024 Sep 11:132555. doi: 10.1016/j.ijcard.2024.132555. Online ahead of print.
   
   
2. Treatment Strategy of Atrial Functional Mitral Regurgitation: Consideration of the Mechanistic Subtypes
   JACC Cardiovasc Imaging. 2024 Sep 4:S1936-878X(24)00339-5. doi: 10.1016/j.jcmg.2024.07.027. Online ahead of print.
   
   
3. Fibro-Calcific Imaging: A Step Towards a More Comprehensive Approach to Aortic Valve Pathophysiology?
   JACC Cardiovasc Imaging. 2024 Sep 2:S1936-878X(24)00310-3. doi: 10.1016/j.jcmg.2024.07.020. Online ahead of print.
   
   
4. Management strategies and outcomes in pregnancy-related acute aortic dissection: a multicentre cohort study in China
   Heart. 2024 Sep 12:heartjnl-2024-324009. doi: 10.1136/heartjnl-2024-324009. Online ahead of print.
   
   
5. Diagnosis of congenital heart disease in adulthood: How often, how relevant?
   Am J Cardiol. 2024 Sep 10:S0002-9149(24)00656-8. doi: 10.1016/j.amjcard.2024.09.004. Online ahead of print.
   
   
6. The Charlson comorbidity index and outcomes after cardiac surgery: Look beyond the heart
   Int J Cardiol. 2024 Sep 10:132540. doi: 10.1016/j.ijcard.2024.132540. Online ahead of print.
   
   
7. Temporal Trends in Prevalence of Bicuspid Aortic Valves in Patients Undergoing Surgical Aortic Valve Replacement
   JACC Cardiovasc Interv. 2024 Sep 9;17(17):2088-2089. doi: 10.1016/j.jcin.2024.07.024.
   
   
8. Volume-Adjusted Annular Sizing of Balloon-Expandable Transcatheter Heart Valves for Severe Bicuspid Aortic Valve Stenosis
   JACC Cardiovasc Interv. 2024 Sep 9;17(17):2085-2087. doi: 10.1016/j.jcin.2024.06.023.
   
   
9. Management of Pulmonary Congestion in Patients With Aortic Stenosis: A Need for Improvement
   JACC Cardiovasc Interv. 2024 Sep 9;17(17):2067-2069. doi: 10.1016/j.jcin.2024.07.027.
   
   
10. Management of Fluid Overload in Patients With Severe Aortic Stenosis (EASE-TAVR): A Randomized Controlled Trial
    JACC Cardiovasc Interv. 2024 Sep 9;17(17):2054-2066. doi: 10.1016/j.jcin.2024.06.022.

View More

1. Valve-in-Ring Transcatheter Mitral Valve Replacement in a Fluoroscopically Invisible Ring
   JACC Cardiovasc Interv. 2024 Jul 29:S1936-8798(24)00954-3. doi: 10.1016/j.jcin.2024.06.029. Online ahead of print.
   
   
2. Curtain Up for LAMPOON in Transcatheter Mitral Valve Replacement!
   JACC Cardiovasc Interv. 2024 Aug 28:S1936-8798(24)01071-9. doi: 10.1016/j.jcin.2024.08.002. Online ahead of print.
   
   
3. 5-Year Outcomes of Anterior Mitral Leaflet Laceration to Prevent Outflow Obstruction
   JACC Cardiovasc Interv. 2024 Jul 12:S1936-8798(24)00861-6. doi: 10.1016/j.jcin.2024.05.041. Online ahead of print.
   
   
4. Transcatheter Valve-in-Valve Implantation After Transcatheter Tricuspid Valve Replacement in a Patient With Rheumatic Heart Disease
   JACC Cardiovasc Interv. 2024 Aug 25:S1936-8798(24)01034-3. doi: 10.1016/j.jcin.2024.07.037. Online ahead of print.
   
   
5. Direct Electrosurgical Traversal With Radiofrequency to Prevent Obstruction in Left Ventricular Outflow Tract (DETROIT)
   JACC Cardiovasc Interv. 2024 Aug 28:S1936-8798(24)00981-6. doi: 10.1016/j.jcin.2024.07.017. Online ahead of print.
   
   
6. 3-Year Outcomes of Tricuspid Transcatheter Edge-to-Edge Repair: Illuminating the Path Forward
   JACC Cardiovasc Interv. 2024 Aug 22:S1936-8798(24)01006-9. doi: 10.1016/j.jcin.2024.07.020. Online ahead of print.
   
   
7. Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: 3-Year Outcomes From the TRILUMINATE Study
   JACC Cardiovasc Interv. 2024 Jul 26:S1936-8798(24)00851-3. doi: 10.1016/j.jcin.2024.05.036. Online ahead of print.
   
   
8. TMVR With Dedicated Devices in Mitral Annular Calcification: A Possible Path in a Rocky Way
   JACC Cardiovasc Interv. 2024 Aug 28:S1936-8798(24)01087-2. doi: 10.1016/j.jcin.2024.08.010. Online ahead of print.
   
   
9. Outcomes Following Transcatheter Mitral Valve Replacement Using Dedicated Devices in Patients With Mitral Annular Calcification
   JACC Cardiovasc Interv. 2024 Aug 27:S1936-8798(24)01035-5. doi: 10.1016/j.jcin.2024.07.038. Online ahead of print.
   
   
10. Clinical Utility of LA Indices in Chronic Severe Aortic Regurgitation: A Comes Before V
    JACC Cardiovasc Imaging. 2024 Aug 25:S1936-878X(24)00341-3. doi: 10.1016/j.jcmg.2024.07.028. Online ahead of print.

View More